July 16, 2014 / 4:14 PM / 4 years ago

BUZZ-U.S. Stocks on the Move-Time Warner, ZipRealty, Iradimed, BioAmber

(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for more market insights, including options activity, ; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) U.S. stocks advanced on Wednesday and the Dow surged to a new intraday high, buoyed by the latest merger news, as investors sorted through the latest batch of corporate earnings. The Dow Jones industrial average was up 0.30 percent at 17,111.24 and the S&P 500 was up 0.24 percent at 1,977.98.

** TIME WARNER INC, $82.09, +15.60 pct

** TWENTY-FIRST CENTURY FOX INC, $33.51, -4.77 pct

Rupert Murdoch’s 21st Century Fox said it made a bid to buy media conglomerate Time Warner Inc but was rebuffed. The bid was worth roughly $80 billion, or $85 per share in cash and stock, a source familiar with the situation told Reuters.

** ZIPREALTY INC, $6.71, +122.14 pct

The real estate information provider said on Tuesday that Realogy Holdings Corp RLGY.N, which provides Internet-based residential real estate services, agreed to buy it for about $166 million. The deal is expected to close in third quarter of 2014.

** IRADIMED CORP, $8.73, +39.68 pct

The medical device maker’s stock rose as much as 80 pct to $11.27, valuing company at $114.4 million. Offering of 2 million shares priced at $6.25/share, slightly above expected price range of $5-$6. Offering raises $12.5 million


The telecom software maker said it expects second-quarter revenue below analysts’ expectations as it deferred revenue from two sizable contracts and faced delays in signing several others. The company expects to report an adjusted operating loss of $6-$7 million for the quarter ended June 30. It had earlier forecast near breakeven operations.

** ICAD INC, $8.41, +17.95 pct

The image analysis and radiation therapy provider said it had agreed to buy private companies DermEbx and Radion in a cash-and-stock deal worth about $12.6 million to expand its radiotherapy services

** LANNETT CO INC, $39.83, -15.42 pct

** IMPAX LABORATORIES INC, $28.49, -0.59 pct

Generic drugmaker Lannett said it was subpoenaed by the Connecticut Attorney General regarding possible price fixing of its generic heart drug, digoxin.

Lannet’s competitor Impax is also being investigated on the subject.

** BIOAMBER INC, $12.02, -15.41 pct

The chemical company offered 2.8 million shares, representing 15 percent of its outstanding shares. The offering was priced at $12 apiece, 15.5 percent below the stock’s Tuesday’s close.

The stock was the second-biggest percentage loser on the NYSE. It has gained more than 70 percent in the past 12 months.

** VENAXIS INC, $1.9901, -10.76 pct

The diagnostics company said FDA seeks additional information on the company’s appendicitis test, which was submitted for marketing approval in March. Says compiling responses to the requests and expects to engage in discussions in the coming weeks.

** POZEN INC, $8.21, -7.23 pct

The drug developer said FDA has set action date of Dec. 30 to decide on Pozen’s re-submission of a marketing application for its experimental pain medication and could issue another “complete response letter” if deficiencies at a supplier’s plant were not satisfactorily addressed by then. The FDA rejected the drug in April, citing deficiencies at the manufacturing facility of an ingredient supplier. A complete response letter lists regulatory concerns that need to be addressed before a drug is approved.


Italy’s GTECH will buy U.S. slot machine maker International Game Technology for $6.4 billion including debt, shifting the lottery operator’s centre of gravity away from its struggling domestic market.

** JOY GLOBAL INC, $63.92, +6.27 pct

The mining equipment maker’s shares up on takeover speculations, says Theflyonthewall.com. Tweets discuss reports of Swedan’s Atlas Copco AB being interested in buying Joy Global but some tweets call it a rumor, saying report recalled by source. Joy Global spokeswoman declines comment. Intra-day volume highest since February 2013.

** FIREEYE INC, $34.62, +2.37 pct

Goldman Sachs began coverage of network security software make with a “buy” rating and price target of $42. “Following significant investor concern around weaker product revenue growth in 1Q14, we expect growth to re-accelerate in 2Q14, following a wave of recent product launches,” analysts said

** PRECISION DRILLING CORP, $13.84, +3.28 pct

The oil and gas services provider boosted its drilling services technology through an alliance with Schlumberger NV, the world’s largest oilfield services provider. Agreement extends to Canada and lower 48 states in the United States.

** BANK OF AMERICA CORP, $15.489, -2.03 pct

The second-largest U.S. bank reported a 43 percent drop in second-quarter profit, falling short of Wall Street estimates, as revenue from mortgages fell and litigation costs soared. Earnings attributable to shareholders fell to $2.04 billion, or 19 cents per share, in the three months ended June 30 from $3.58 billion, or 32 cents per share, a year earlier.

Bank of America has offered $13 billion to settle a probe into mortgage securities sold by the bank, the Wall Street Journal reported, citing sources.

** MGIC INVESTMENT CORP, $7.64, -8.50 pct

The mortgage insurer reported a lower-than-expected second-quarter said may not continue to meet government-sponsored profit as net premiums earned fall 13 percent. Total revenue down 12 pct at $231.2 million in the quarter ended June 30. The company Fannie Mae and Freddie Mac’s mortgage insurer eligibility requirements and that returns may decrease if company is required to maintain significantly more capital.

** YAHOO INC, $33.905, -4.79 pct

Yahoo’s net revenue, which excludes fees paid to partner websites, decreased 3 percent year-on-year to $1.04 billion in the three months ended June 30. Analysts polled by Thomson Reuters I/B/E/S were looking for net revenue of $1.084 billion.

** INTEL CORP, $33.92, +6.97 pct

** ADVANCED MICRO DEVICES INC, $4.64, +2.43 pct

Intel believes the worst is over for a personal computer industry hammered by the mobile revolution. The Santa Clara, California chipmaker forecast third-quarter revenue above Wall Street’s expectations on Tuesday

At least 19 brokerages raised their price targets on the stock to $29-$45, while two brokerages raised their ratings to an equivalent of “buy”.

Smaller rival Advanced Micro Devices Inc’s shares are also up in premarket, boosted by Intel’s third-quarter and full-year revenue outlook.

** APPLE INC, $96.315, +1.04 pct


** BLACKBERRY LTD, $10.3917, -8.04 pct

IBM Corp said it will partner exclusively with Apple Inc to sell iPhones and iPads loaded with applications geared at enterprise clients.

This comes as a threat to BlackBerry, which has increasingly targeted its secure software at businesses as part of an effort to turn the company around after losing ground to Apple’s iPhone and Samsung Electronics Co.


Susquehanna Financial Group downgraded the world’s largest contract chipmaker’s shares to “negative” from “neutral”, saying the company was likely to face higher competition if Apple Inc moves some orders for 20 nanometer chips to GlobalFoundries in 2015. Taiwan Semiconductor is likely to see lower demand for chips below 20 nanometers even as it moderately raises capital investment in 2015 to commercialize 10 nanometer chips, analyst Mehdi Hosseini said.

** TEXTRON INC, $39.1, +1.90 pct

The world’s largest business jet maker said business jet deliveries rose to 36 from 20 in second quarter. Kept 2014 earnings forecast of $1.92-$2.12/share. “Good execution and volumes helped overcome our conservative expectations for Beechcraft-related costs,” says RBC Capital Markets’ Robert Stallard.

** HERSHEY CO, $92.37, -2.42 pct

The No. 1 candy producer in the United States on Tuesday raised its chocolate prices for the first time in three years, a sign that a year-long soaring cocoa market is eating into confectioners’ profits.

** ARES CAPITAL CORP, $17.028, -2.14 pct

Investment firm priced an offering of 13.5 million shares of its common stock. Offering represents about 4.5 pct of total outstanding shares as of May 5.


The regional bank said second-quarter profit was down 6 pct as net interest income fell. Institutional banking unit earnings fall 23 pct to $470 million. (Compiled by Sneha Banerjee in Bangalore; Edited by Don Sebastian)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below